Get started
Work

Azithromycin For Bronchiolitis Obliterans Following Allogeneic Hematopoietic Stem Cell Transplantation

Year: 2010
Type: article
Study design: Observational Study
Abstract: Bronchiolitis obliterans (BO) following HSCT is associated with significant morbidity and mortality with few effective therapies. Current therapy includes corticosteroids and immunosuppression. Azithromycin has been used to manage BO following lung transplantation; however it has been reported in few HSCT patients. We report our experience in 46 patients receiving azithromycin for BO.
DOI: 10.1016/j.bbmt.2009.12.353
Authors: E. Maciuleviciute, J.A. Burzynski, R.C. Wolf, S.M. Ansell, F.K. Buadi, D. Dingli, A. Dispenzieri, D.A. Gastineau, M.A. Gertz, D.J. Inwards, P.B. Johnston, S. Kumar, M.Q. Lacy, M.R. Litzow, I.N.M. Micallef, L.E. Porrata, W.J. Hogan
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2082627423
FWCI:
Cites:
Cited by:
Related to: 10